Table 2.
Combined clinical events (death, reinfarction, cardiopulmonary arrest, stroke and severe bleeding) according to drug use
| 30 days n (%) | 6 months n (%) | 12 months n (%) | |
|---|---|---|---|
| ASA | |||
| Yes | 140 (6.1) | 225 (10.8) | 269 (14.8) |
| No | 12 (9.4) | 21 (18.4)* | 27 (23.9)* |
| Clopidogrel | |||
| Yes | 111 (5.9) | 183 (10.7) | 296 (14.8) |
| No | 41 (7.6) | 63 (13) | 75 (17) |
| Beta-blocker | |||
| Yes | 92 (4.7) | 160 (9.1) | 199 (12.9) |
| No | 58 (12.7)** | 83 (39)** | 94 (24.4)* |
| ACE/AT1RB | |||
| Yes | 79 (4.8) | 136 (9.2) | 169 (13.2) |
| No | 73 (9.3)** | 110 (15.6)** | 127 (19.4)** |
| Statin | |||
| Yes | 127 (5.7) | 214 (10.5) | 261 (14.6) |
| No | 25 (14.7)** | 32 (21.1)** | 35 (24.3)** |
*
p < 0.05;
**
p < 0.001.
ASA: acetylsalicylic acid; ACEI/AT1RB: angiotensin-converting enzyme inhibitors/angiotensin-receptor blocker